Fluvoxamine Extended-Release Capsules Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Capsules

Available Strengths: Luvox CR

Reference Brands: Luvox(US); Fevarin(EU)

Category: Antipsychotropic Drugs

Fluvoxamine Extended-Release Capsules is available in Extended-Release Capsules and strengths such as Luvox CR. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fluvoxamine Extended-Release Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Fluvoxamine Extended-Release Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: In the United States, fluvoxamine extended-release (ER) capsules are FDA-approved for the treatment of obsessive-compulsive disorder (OCD) and social anxiety disorder (SAD). As a selective serotonin reuptake inhibitor (SSRI), it carries a Boxed Warning for increased risk of suicidal thoughts in adolescents and young adults. Regulatory compliance includes GMP standards, bioequivalence data for generics, and strict labeling and safety reporting. Ongoing pharmacovigilance is required through FDA’s FAERS system. In the European Union, fluvoxamine is typically available in immediate-release tablet form, with the ER capsule less commonly approved. EU regulatory approval follows centralized or national procedures, with mandatory Risk Management Plans (RMPs), Periodic Safety Update Reports (PSURs), and comprehensive clinical data. For regulatory-ready sourcing, visit Pharmatradz.com.